PRECISION. EXPERIENCE. TRUST.

Robotic &
minimally invasive visceral surgery

Specialized minimally invasive visceral surgery combining advanced robotics, extensive operative experience and consistently personal care.

SPEZIELLE VISZERALCHIRURGIE Facharzt für Viszeralchirurgie und spezielle Viszeralchirurgie
DA VINCI Fortgeschrittene Erfahrung in der robotergestützten Chirurgie
FORSCHUNG & LEHRE Habilitation, universitäre Lehre und wissenschaftliche Publikationen
PATIENT IM MITTELPUNKT Individuelle Beratung und verständliche Behandlungsplanung
15 JAHRE CHIRURGISCHE ERFAHRUNG Langjährige operative Expertise in der modernen Viszeralchirurgie
LEISTUNGEN & SPEZIALGEBIETE

Spezialisierte Chirurgie. Individuell geplant.

Surgical Specialities

Mein Schwerpunkt liegt auf robotergestützten und minimalinvasiven Verfahren. Jede Behandlung wird anhand der Erkrankung, der anatomischen Situation und der persönlichen Bedürfnisse sorgfältig ausgewählt.

ROBOTIC & MINIMALLY INVASIVE SURGERY

Robotic Colorectal Surgery

Precise treatment of benign, inflammatory and oncological diseases of the colon, rectum and pelvic floor—individually planned and coordinated across disciplines.

BENIGN & INFLAMMATORY

Diseases of the colon and rectum

Each condition requires its own diagnostic and treatment strategy. Surgery is not always necessary, but may become important when complications or persistent symptoms occur.

Medical atlas illustration of diverticular disease and diverticulitis
01

Diverticular Disease & Diverticulitis

What is it?

Diverticula are small pouches in the wall of the colon, most commonly in the sigmoid colon. When they become inflamed, this is called diverticulitis. Complications may include abscesses, fistulas, narrowing or perforation.

Treatment

Uncomplicated cases can often be managed without surgery. Image-guided drainage may be required for an abscess. Surgery is considered particularly for perforation, peritonitis, fistulas, significant narrowing or recurrent complicated disease.

Medical atlas illustration of Crohn's disease
02

Crohn's Disease

What is it?

Crohn's disease is a chronic inflammatory bowel disease that can affect different parts of the digestive tract. Typical complications include strictures, fistulas, abscesses and bowel obstruction.

Treatment

Medical control of inflammation is central. Surgery may be needed for strictures, fistulas, abscesses, perforation or inadequate response to medication. It treats the complication but does not permanently cure the underlying disease.

Medical atlas illustration of ulcerative colitis
03

Ulcerative Colitis

What is it?

Ulcerative colitis is a chronic inflammatory disease of the colon. Inflammation typically begins in the rectum and may extend continuously through further sections of the colon.

Treatment

Depending on disease activity, anti-inflammatory, immunomodulating or targeted medicines are used. Surgery may be necessary for treatment-resistant disease, severe complications, precancerous changes or cancer. An ileoanal pouch reconstruction may be possible for suitable patients.

Medical atlas illustration of colorectal polyps and polyposis
04

Colorectal Polyps & Polyposis

What is it?

Polyps are changes in the lining of the colon or rectum. Many remain benign, but certain adenomas or serrated lesions can develop into cancer over time. In inherited polyposis syndromes, numerous polyps may arise at a young age.

Treatment

Most polyps are removed during colonoscopy and examined microscopically. Surgery may be required when complete endoscopic removal is not possible, cancer is suspected or an inherited syndrome carries a high cancer risk.

Medical atlas illustration of colon volvulus and benign obstruction
05

Colon Volvulus & Benign Obstruction

What is it?

In a colon volvulus, a segment of the colon twists around itself, potentially blocking the bowel and its blood supply. Benign obstruction may also result from strictures, adhesions or inflammatory changes.

Treatment

Complete bowel obstruction is a medical emergency. A sigmoid volvulus can often first be decompressed endoscopically if the bowel is viable. Because recurrence is common, planned surgery often follows. Urgent surgery is required if blood supply is compromised, perforation or peritonitis occurs.

Medical atlas illustration of ischemic colitis
06

Ischemic Colitis

What is it?

In ischemic colitis, part of the colon temporarily or permanently receives insufficient blood flow. The condition may begin suddenly with abdominal pain and bloody stool.

Treatment

Milder cases may be managed with fluids, bowel rest, treatment of the cause and close monitoring. Bowel necrosis, perforation, peritonitis or ongoing deterioration require urgent surgery.

Medical atlas cutaway illustration of rectal prolapse
07

Rectal Prolapse

What is it?

In rectal prolapse, the wall of the rectum protrudes partially or completely. Associated symptoms may include difficulty emptying, incontinence, mucus discharge or bleeding.

Treatment

Bowel regulation and pelvic-floor therapy can relieve symptoms, but complete prolapse is usually treated surgically. Depending on overall health and anatomy, abdominal, minimally invasive or perineal procedures may be considered.

ONCOLOGICAL DISEASES

Colon and Rectal Cancer

Both tumour types are colorectal cancers, but they differ especially in local staging, treatment before surgery and operative strategy.

Medical atlas illustration of colon cancer
08 · COLON

Colon Cancer

What is it?

Colon cancer is a malignant disease of the large bowel that often develops from precursors such as adenomas. Early tumours may cause no symptoms. Possible signs include blood in the stool, altered bowel habits, anaemia, weight loss or obstruction.

Treatment

For localised tumours, oncological removal of the affected bowel segment and its regional lymph nodes is the central treatment. Additional chemotherapy depends on stage, risk factors and molecular features.

Medical atlas illustration of rectal cancer in the pelvis
09 · RECTUM

Rectal Cancer

What is it?

Rectal cancer develops in the final part of the large bowel. Because of the confined anatomy of the pelvis, its treatment differs substantially from that of colon cancer.

Treatment

Favourable early tumours may be removed locally in carefully selected patients. For locally advanced disease, chemotherapy and radiation are often combined before surgery. Surgery follows oncological principles, usually including complete removal of the mesorectum.

US GUIDELINES & CANCER STATISTICS

Diagnosis, Numbers and Treatment Pathways

108,860estimated new colon cancers in the US in 2026
49,990estimated new rectal cancers in the US in 2026
55,230estimated colorectal cancer deaths

Population-based estimates; not an individual prognosis. American Cancer Society ↗

Localised91.3%
Regional75.2%
Distant16.9%

Relative five-year survival rates across large patient groups. These figures are not an individual prognosis.

NCI SEER ↗
SHARED DIAGNOSTIC WORK-UP

Colon and rectum

  • Medical history and physical examination
  • Complete colonoscopy with biopsy
  • CEA and further laboratory tests
  • CT of chest, abdomen and pelvis
  • MMR/MSI testing and molecular diagnostics when indicated
  • Assessment for hereditary cancer syndromes
  • Multidisciplinary tumour board
ADDITIONAL RECTAL CANCER STAGING

Precise local staging

  • Digital rectal examination
  • Rigid proctoscopy to determine tumour height
  • High-resolution pelvic MRI
  • Assessment of mesorectum and circumferential margin
  • Relationship to the sphincter complex
  • Endorectal ultrasound in selected early tumours
COLON CANCER

Stage-based treatment

EARLY

Some very early cancers within polyps can be removed completely endoscopically. Histological risk features and secure complete removal are decisive.

I

Oncological removal of the affected bowel segment and regional lymph nodes.

II

Surgery is the foundation; additional chemotherapy is considered according to individual risk factors and molecular features.

III

Adjuvant chemotherapy is generally recommended after oncological surgery.

IV

Individual planning with systemic therapy, targeted medicines or immunotherapy and—in selected patients—surgery or local treatment of metastases.

RECTAL CANCER

Multimodal treatment

EARLY

Small favourable tumours may be removed locally in carefully selected patients. Higher-risk disease requires oncological rectal resection.

TNT

Total neoadjuvant therapy is frequently used for locally advanced disease: chemotherapy and radiation are delivered before surgery in an individually selected sequence.

TME

Surgery aims for complete tumour removal, total mesorectal excision, clear margins and—when oncologically possible—preservation of the sphincter.

W&W

After a complete clinical response, a closely monitored watch-and-wait strategy may be discussed for selected patients in specialised centres.

Medical basis

This structure follows current US professional and patient information. Individual treatment is determined after complete diagnostic evaluation and multidisciplinary tumour-board review.

ROBOTIC COLORECTAL SURGERY

Precision in complex procedures

Robotic surgery can be particularly useful for procedures in the confined pelvis or for complex reconstructions. The system provides high-definition three-dimensional vision and precise instrument movement.

The robot does not operate independently. Every movement is fully controlled by the surgeon. The operative approach is selected according to the disease, anatomy, previous surgery and the individual medical situation.

01Colon and rectal cancer
02Diverticular disease
03Inflammatory bowel disease
04Rectal prolapse & pelvic floor
05Complex reconstructions & repeat surgery
PERSONAL & MULTIDISCIPLINARY PLANNING

Every treatment begins with a precise diagnosis.

For cancer, treatment is planned with gastroenterology, oncology, radiology, radiation oncology and pathology in a multidisciplinary tumour board.

The information on this page is intended for general patient education and does not replace a personal medical examination or individual treatment recommendation.

Services & Specialties
SPECIALIZED ONCOLOGICAL SURGERY

Peritoneal Surface Malignancies

Peritoneal carcinosis occurs when cancer spreads to the membrane lining the abdominal cavity. Modern treatment may combine carefully selected surgery with regional chemotherapy delivered directly to the compartment where the disease is located.

UNDERSTANDING PERITONEAL CARCINOSIS

When cancer spreads within the abdominal cavity

Cancer cells may settle on the peritoneal lining and involve several abdominal organs. Because the peritoneum forms a distinct anatomical compartment, treatment often requires a strategy beyond systemic chemotherapy alone.

Where can it originate?

Peritoneal disease can arise from several primary cancers. The biology of the original tumour remains central to selecting the safest and most appropriate treatment.

Colorectal cancerGastric cancerAppendiceal cancerOvarian cancerMesotheliomaOther malignancies
Medical illustration showing typical distribution of peritoneal metastases including diaphragmatic nodules, peritoneal implants, omental cake, bowel surface deposits, pelvic deposits and ascites
Typical distribution patterns of peritoneal metastases. The illustration is educational and does not represent an individual patient.
BEFORE TREATMENT

A structured assessment guides every decision

Imaging, staging procedures and sometimes diagnostic laparoscopy help determine disease extent and whether a regional or operative approach is appropriate.

01

Review the diagnosis

Pathology, tumour origin, previous treatment and the current clinical situation are reviewed.

02

Map disease extent

Cross-sectional imaging and, where appropriate, diagnostic procedures assess distribution and resectability.

03

Assess fitness

General health, organ function, nutritional status and ability to recover from treatment are considered.

04

Multidisciplinary plan

Surgical oncology, medical oncology, radiology and pathology contribute to an individualized recommendation.

OPERATIVE & REGIONAL TREATMENT

Cytoreductive surgery and HIPEC

These treatments are distinct but may be combined in selected patients: surgery addresses visible tumour deposits, while HIPEC exposes remaining peritoneal surfaces to heated chemotherapy during the same operation.

01 CYTOREDUCTIVE SURGERY

Removing visible peritoneal disease

Cytoreductive surgery (CRS) is an extensive abdominal operation designed to remove as much visible disease as safely possible while preserving essential organ and bowel function.

  • Systematic assessment of the abdomen and pelvis
  • Removal of peritoneal nodules, involved peritoneum and omental disease
  • Organ resection or reconstruction only when required by tumour location
  • Careful balance between completeness of cytoreduction and functional preservation
02 IMPORTANT CONSIDERATIONS

Major surgery requires careful selection

CRS involves substantial tissue manipulation and a recovery period of several weeks. Potential complications include bleeding, infection and problems involving bowel reconstructions. Preoperative preparation, experienced multidisciplinary care and close postoperative monitoring are essential.

View further clinical detail about CRS

How it works

The surgeon explores all abdominal regions, identifies disease on the peritoneum and organ surfaces, and removes affected tissue where this can be achieved safely. Depending on disease location, this may include parts of the colon, small bowel, ovaries, uterus, spleen or other structures.

Treatment goal

The objective is complete or near-complete macroscopic cytoreduction while maintaining adequate bowel length and function. The realistic goal and expected benefit vary by tumour biology and disease distribution.

Medical diagram of HIPEC showing heated chemotherapy solution, reservoir, perfusion pump, heat exchanger, inflow and outflow catheters, temperature probes and abdominal circulation at 41 to 43 degrees Celsius
02 HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY

Heated chemotherapy delivered directly to the abdomen

HIPEC circulates a heated chemotherapy solution through the abdominal cavity, usually immediately after cytoreductive surgery. Temperature, duration and medication depend on tumour type and the centre's protocol.

  • Regional delivery creates a high local drug concentration
  • Heat may enhance tissue penetration and cytotoxic activity
  • Continuous circulation distributes the solution over peritoneal surfaces
  • HIPEC is a single intraoperative treatment, not a substitute for all systemic therapy
View further clinical detail about HIPEC

How it works

After cytoreduction, inflow and outflow catheters circulate warmed perfusate through the abdominal cavity. The team monitors temperature and distribution before the solution is removed and the operation is completed.

Why local delivery matters

The peritoneal compartment permits high local exposure while systemic absorption is comparatively limited. The expected value of HIPEC depends on the primary tumour, completeness of surgery, regimen and individual disease characteristics.

PRESSURIZED AEROSOL THERAPY

PIPAC and PITAC

Pressurized aerosol techniques deliver regional chemotherapy through minimally invasive access. They do not remove tumour tissue and should be considered within a specialized oncological treatment plan.

03 PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY

PIPAC: regional treatment through laparoscopy

PIPAC uses a specialized nebulizer to distribute chemotherapy as a fine aerosol in the pressurized abdominal cavity. It is performed laparoscopically in an operating-room setting, generally under general anaesthesia.

  • Small laparoscopic access points and camera visualization
  • Controlled aerosol delivery within a closed system
  • Repeatable treatment in selected protocols
  • Potential use for unresectable disease, palliation or within downstaging strategies
Medical diagram of PIPAC showing laparoscopic access, carbon dioxide pneumoperitoneum, aerosolizing micropump, chemotherapy aerosol, power injector and closed aerosol waste system
View further clinical detail about PIPAC

Aerosol and pressure

The aerosol format and controlled pressure are intended to improve distribution over exposed peritoneal surfaces. Treatment remains confined to the abdominal cavity and is carried out with occupational safety measures and a closed waste system.

Role in treatment

PIPAC may be discussed when major cytoreductive surgery is not appropriate, as part of symptom-oriented treatment, or in selected multimodal protocols. Availability, medication and treatment intervals vary between specialist centres.

ABDOMINAL COMPARTMENT

PIPAC

Targets disease on the peritoneal surfaces through laparoscopic access to the abdomen.

01Laparoscopic visualization and staging
02Controlled aerosol chemotherapy delivery
03Potentially repeatable in selected treatment plans
THORACIC COMPARTMENT

PITAC

Extends the aerosol concept to the pleural cavity for selected patients with malignant pleural disease. Access is obtained by thoracoscopy, followed by controlled aerosol delivery and drainage.

01Thoracoscopic access to the pleural space
02Pressurized regional chemotherapy exposure
03Protocol-driven treatment at selected specialist centres
Emerging / investigational technique

PIPAC versus PITAC

The same regional aerosol principle, applied to different anatomical compartments.

Aspect
PIPAC
PITAC
Target
Peritoneal cavity (abdomen)
Pleural cavity (thorax)
Access
Laparoscopy
Thoracoscopy
Experience
Growing clinical and research experience
More limited; evolving evidence
Current role
Specialized, protocol-dependent option
Primarily investigational / protocol-driven
CHOOSING THE RIGHT APPROACH

No single treatment fits every patient

Treatment selection integrates tumour biology, disease extent and location, resectability, overall health, previous therapies and each patient's goals.

Extensive surgery

CRS with or without HIPEC

May be considered when peritoneal disease appears technically removable and the patient is fit for a major multimodal procedure.

  • Potentially resectable disease
  • Adequate health and organ function
  • Careful specialist assessment
  • Commitment to recovery and follow-up
Minimally invasive

PIPAC

May be discussed when major cytoreduction is not appropriate or as part of a specialized multimodal treatment strategy.

  • Regional therapy without tumour removal
  • Protocol-dependent repeat treatments
  • Specialized equipment and expertise
  • Evidence and availability continue to evolve
Systemic treatment

Medical oncology

Systemic chemotherapy, targeted treatment or immunotherapy remains central for many patients and may be combined with or used instead of regional procedures.

  • Tumour-specific treatment plan
  • Sequencing before or after surgery
  • Response assessment over time
  • Joint surgical-oncology decision
OUR APPROACH

Clear information. Honest expectations. Individual planning.

Peritoneal carcinosis is complex. Our aim is to explain the available options, coordinate specialist assessment and define a realistic treatment strategy aligned with the patient's disease, health and personal priorities.

01
Thorough assessmentReview of imaging, pathology, prior treatment and disease distribution.
02
Multidisciplinary collaborationClose coordination with medical oncology, imaging and pathology specialists.
03
Balanced consultationTransparent discussion of expected benefit, risks, alternatives and recovery.
04
Individual treatment planIntegration of operative, regional and systemic treatment where appropriate.

This information supports, but does not replace, individual medical advice. Treatment suitability can only be determined after personal consultation and review of the complete medical record.

PD. Dr. Omar Thaher Portrait von PD. Dr. Omar Thaher aus dem Lebenslauf
01 German Board-Certified Visceral Surgeon State Medical Association of Hesse · Germany
02 Special Visceral Surgery Medical Association of Westphalia-Lippe · Germany
03 Proctology Medical Association of Westphalia-Lippe · Germany
04 Robotic & Minimally Invasive Surgery Clinical surgical focus
05 Gastrointestinal Surgery Clinical surgical focus
06 Oncological Surgery Clinical surgical focus
PD. Dr. Omar Thaher Consultant General, Visceral & Robotic Surgeon German Board-Certified · 15 Years of Surgical Experience
DA VINCI
ÜBER MICH

Moderne Chirurgie mit Präzision, Erfahrung und Menschlichkeit.

Als Facharzt für Viszeralchirurgie und spezielle Viszeralchirurgie liegt mein besonderer Schwerpunkt auf der roboterassistierten und minimalinvasiven Behandlung komplexer Erkrankungen des Bauchraums.

Meine operative Tätigkeit umfasst insbesondere die kolorektale und Beckenbodenchirurgie, Reflux- und Oberbauchchirurgie, komplexe Hernienchirurgie sowie die Behandlung der Peritonealkarzinose. Ergänzt wird die klinische Arbeit durch universitäre Lehre, wissenschaftliche Forschung und den Aufbau moderner robotischer Operationsprogramme.

„Bei aller Spezialisierung und dem Einsatz modernster Techniken steht der Mensch als Individuum im Mittelpunkt meines Denkens und Handelns.“
Facharztqualifikationen Viszeralchirurgie, spezielle Viszeralchirurgie und Proktologie
Roboterchirurgische Expertise Fortgeschrittene Erfahrung mit da Vinci
Wissenschaft & Lehre Habilitation, universitäre Lehre und Publikationen
Aktuelle Aufgabe Aufbau der Roboterchirurgie mit Schwerpunkt kolorektale Chirurgie
ABOUT ME

PD. Dr. Omar Thaher

Consultant General, Visceral & Robotic Surgeon

German Board-Certified · Special Visceral Surgery & Proctology · 15 Years of Surgical Experience

German board certification and 15 years of operative experience in general, visceral and specialised visceral surgery form the foundation of my clinical work.

The principal clinical focus lies in robotic and minimally invasive surgery, complex abdominal procedures and the surgical treatment of benign and malignant diseases of the gastrointestinal tract. Operative expertise is combined with clinical leadership, academic research and surgical education.

“Modern surgery requires precision, experience and innovation. Yet even with the most advanced technology, the individual patient must always remain at the centre of every medical decision.”
MY APPROACH TO PATIENT CARE

Individual planning. Clear communication. Modern surgical care.

Every patient and every clinical situation is different. Careful evaluation, clear communication and an individually tailored treatment plan therefore form the foundation of my work.

01
Evidence-based careCurrent medical evidence and modern, patient-centred techniques provide the basis for every treatment decision.
02
Individual choice of procedureMinimally invasive and robotic procedures are used whenever they are medically appropriate for the individual clinical situation.
03
Patient at the centreTechnical precision is valuable when it supports safety, structured recovery and long-term well-being.
CLINICAL EXPERTISE

Specialised surgical expertise

Extensive operative experience, modern techniques and multidisciplinary decision-making shape the treatment of complex abdominal conditions.

01

Robotic & Minimally Invasive Surgery

Extensive experience in robotic and minimally invasive procedures using the da Vinci surgical system, including complex operations of the upper gastrointestinal tract, colon and rectum, abdominal wall and pelvic floor.

02

Oncological Surgery

Surgical care for malignant diseases of the abdominal organs. Oncological procedures are planned within a multidisciplinary framework and adapted to the individual clinical situation.

03

Gastrointestinal Surgery

Open, minimally invasive and robotic treatment of benign and malignant diseases of the oesophagus, stomach, small intestine, colon and rectum.

04

Peritoneal Surface Malignancies

A particular clinical focus is the treatment of peritoneal carcinomatosis, including cytoreductive surgery and advanced procedures such as HIPEC, PIPAC and PITAC.

05

Colorectal Surgery

Treatment of benign and malignant diseases of the colon and rectum using established open, minimally invasive and robotic techniques.

06

Hernia & Abdominal Wall Surgery

Treatment of primary, recurrent, incisional and complex abdominal wall hernias using individually selected open, minimally invasive or robotic techniques.

07

Proctological Surgery

Modern diagnostic and surgical treatment of common and complex proctological conditions, with particular attention to preserving function and supporting recovery.

PROFESSIONAL CAREER

Clinical experience and surgical leadership

The professional path combines comprehensive surgical training with increasing clinical responsibility and senior leadership roles in Germany and Switzerland.

  1. 01

    Lead Physician | Department of Surgery

    Spital HerisauHerisau · Switzerland

  2. 02

    Lead Senior Consultant & Deputy Head of Department

    Department of General and Visceral SurgeryUniversity Hospital Herne · Ruhr University Bochum
    Herne · Germany

  3. 03

    Managing Senior Consultant & Deputy Head of Department

    Department of General and Visceral SurgeryUniversity Hospital Herne · Ruhr University Bochum
    Herne · Germany

  4. 04

    Senior Consultant

    Department of General and Visceral SurgeryUniversity Hospital Herne · Ruhr University Bochum
    Herne · Germany

  5. 05

    Surgical Resident | General, Visceral & Thoracic Surgery

    Klinikum Darmstadt GmbHDarmstadt · Germany

  6. 06

    Surgical Resident | General & Visceral Surgery

    Bürgerhospital Frankfurt am MainFrankfurt am Main · Germany

  7. 07

    Surgical Resident | General, Visceral & Minimally Invasive Surgery

    Klinikum Bad HersfeldBad Hersfeld · Germany

MEDICAL EDUCATION & LICENSURE

Medical training and professional recognition

Medical studies, professional licensure and recognition of the medical diploma in Switzerland form the foundation of clinical practice.

01

Recognition of Medical Diploma in Switzerland

Medical Professions Commission – MEBEKO · Switzerland

02

Medical Licence to Practise – Approbation

State Medical Association of Hesse · Germany

03

Medical Studies – Human Medicine

Justus Liebig University Giessen · Giessen · Germany

SURGICAL LEADERSHIP & QUALITY

Reliable structures for better surgical care

Modern surgical care requires more than technical expertise in the operating room. Reliable clinical structures, interdisciplinary collaboration and clearly defined treatment pathways are essential for patient safety and consistent treatment quality.

  • Development of multidisciplinary surgical teams
  • Establishment of clinical and organisational standards
  • Support of certification processes for specialised surgical centres
  • Introduction of modern operative procedures and treatment concepts
  • Quality management and structured evaluation of clinical outcomes
  • Training and supervision of surgical colleagues
TEACHING, EXAMINATION & TRAINING AUTHORISATION

Sharing knowledge. Building responsibility.

Academic teaching combines theoretical knowledge with clinical decision-making, practical surgical skills, risk management and perioperative safety. Structured teaching and individual supervision support the gradual assumption of professional responsibility.

Lecturer in SurgeryFaculty of Medicine · Ruhr University Bochum · Germany
Teaching Coordinator and Lecturer in SurgeryFaculty of Medicine · Ruhr University Bochum · Germany
Examiner for the Final Medical State ExaminationState Examination Office Düsseldorf · Germany
Training Authorisation in Visceral SurgeryUniversity Hospital Herne · Ruhr University Bochum · Herne · Germany
Co-Founder and Lecturer at the GRIPS CentreJustus Liebig University Giessen · Germany
Lecturer in Histology, Anatomy and PhysicsJustus Liebig University Giessen · Germany
PROFESSIONAL & SCIENTIFIC MEMBERSHIPS

Professional exchange across disciplines and borders

DGAVGerman Society for General and Visceral Surgery
DAGGerman Obesity Society
CAADIPSurgical Working Group for Obesity and Metabolic Surgery
ACOAssociation of Surgical Oncology
EHSEuropean Hernia Society
ISSPPInternational Society for the Study of Pleura and Peritoneum
IOSInternational Obesity Society
GBDGlobal Burden of Disease
DOCTORATE & HABILITATION

Academic qualifications

DOCTORATE · DR. MED.

Propensity Score Matching: Sleeve Gastrectomy vs. Gastric Bypass in Older Patients Aged 60 Years and Above

Otto von Guericke University Magdeburg · Germany

Supervisor: Prof. Dr. med. Christine Stroh

HABILITATION

The Significance and Impact of Obesity and Metabolic Surgery in the Federal Republic of Germany

Faculty of Medicine · Ruhr University Bochum · Germany

Supervisor: Prof. Dr. med. Dirk Bausch

RESEARCH & ACADEMIC WORK

Connecting clinical practice with scientific evidence

The continuous evaluation of surgical techniques, treatment pathways and clinical outcomes provides an important foundation for improving patient safety and long-term treatment quality.

  • Robotic and minimally invasive surgery
  • Oncological and visceral surgery
  • Peritoneal surface malignancies
  • Obesity and metabolic surgery
  • Surgical quality and outcome research
  • Digitalisation and artificial intelligence in surgery
INNOVATION & THE FUTURE OF SURGERY

Integrating technology responsibly into care

I have a strong interest in the responsible integration of modern technologies into surgical care. My work focuses particularly on robotic surgery, digital clinical processes and the potential application of artificial intelligence in preoperative preparation and postoperative patient care. My objective is to provide more precise, structured and patient-centred treatment while respecting medical ethics, data protection and patient trust.

A PERSONAL COMMITMENT
“My goal is to combine surgical experience, scientific evidence and modern technology with personal, respectful and transparent patient care. Every treatment decision should be understandable, individually appropriate and focused on the best possible outcome for the patient.”
PD. Dr. Omar Thaher
REFLUX & UPPER ABDOMINAL SURGERY

Reflux Disease & Hiatal Hernias

Modern diagnostics and individually tailored treatment for gastro-oesophageal reflux disease and hiatal hernias—from conservative care to minimally invasive reconstruction.

UNDERSTANDING THE CONDITION

Reflux is more than excess stomach acid.

Gastro-oesophageal reflux disease occurs when stomach contents repeatedly flow back into the oesophagus, causing symptoms or mucosal injury. The central problem is often not acid quantity alone, but an impaired barrier at the junction between the oesophagus and stomach.

This barrier includes the lower oesophageal sphincter, the diaphragm, the angle between oesophagus and stomach, and coordinated oesophageal and gastric motility. A hiatal hernia can impair this interaction, but does not automatically mean that reflux requires treatment.

Not every hiatal hernia requires surgery. Symptoms, anatomy, objective findings and individual risk are assessed together.
Possible mucosal injury

Reflux oesophagitis, erosions, ulcers and peptic narrowing of the oesophagus may occur.

Barrett's oesophagus

Long-standing reflux can lead to mucosal change that may require targeted endoscopic surveillance.

Quality of life and airways

Night-time symptoms, disturbed sleep and selected reflux-associated airway symptoms can significantly affect quality of life.

RECOGNISING SYMPTOMS

Typical and less typical signs

Reflux and hiatal hernias can cause a wide range of symptoms. Careful attribution is particularly important when cough, hoarseness or swallowing difficulty are the main concern.

Person experiencing heartburn

Heartburn

A burning sensation behind the breastbone, often after meals or while lying down.

Person experiencing acid regurgitation

Acid regurgitation

Sour belching or the backflow of stomach contents into the throat.

Person coughing at night

Night-time cough and hoarseness

Reflux may irritate the airways and contribute to cough or hoarseness.

Person experiencing swallowing difficulty

Difficulty swallowing

A sensation that food is sticking in the throat or behind the breastbone.

Illustration of upper abdominal discomfort

Upper abdominal pain and fullness

Pressure, pain, bloating or early satiety in the upper abdomen.

Illustration of a tooth

Dental problems

Repeated acid exposure may affect tooth enamel and oral health.

Typical symptoms

  • Heartburn and burning behind the breastbone
  • Sour or bitter regurgitation
  • Pressure or burning in the upper abdomen
  • Symptoms after meals or while lying down

Other possible symptoms

  • Difficulty or pain when swallowing
  • Hoarseness, chronic cough or a globus sensation
  • Nausea, early satiety, fullness or belching
  • Mechanical pressure with larger paraoesophageal hernias
ANATOMY

Four types of hiatal hernia

The anatomical type influences symptoms, risk and treatment planning. The combination of findings and clinical circumstances is what matters.

Type I · sliding

The junction between the oesophagus and stomach slides above the diaphragm. This is the most common type.

Type II · paraoesophageal

Part of the stomach enters the chest beside the oesophagus while the junction remains in its normal position.

Type III · mixed

Sliding and paraoesophageal components occur together; larger hernias are often of this type.

Type IV · complex

In addition to the stomach, other abdominal organs may move through the enlarged hiatus into the chest.

OBJECTIVE AND STRUCTURED

Diagnostics before treatment

Symptoms alone are not sufficient for an invasive treatment decision. Endoscopy, functional testing and imaging answer different questions and are combined selectively.

Illustration of upper gastrointestinal endoscopy
01 · ENDOSCOPY

Gastroscopy

Assesses mucosa and anatomy: reflux oesophagitis, Barrett's mucosa, narrowing, ulcers, hiatal hernia and the gastro-oesophageal junction. Biopsies are taken when indicated.

Illustration of ambulatory reflux monitoring
02 · REFLUX MONITORING

pH or pH-impedance monitoring

Records acid reflux for 24 hours or wirelessly over several days and—with impedance—also non-acid reflux. It is especially important when endoscopy is negative or symptoms persist.

Illustration of high-resolution oesophageal manometry
03 · FUNCTION

High-resolution manometry

Measures pressure and movement within the oesophagus. It identifies motility disorders, helps exclude achalasia and informs selection of an appropriate operation.

Illustration of a contrast swallow examination
04 · ANATOMY

Contrast swallow

Shows anatomy and dynamics, hernia size and position, passage, possible shortening of the oesophagus or rotation. On its own, however, it does not prove reflux disease.

STEPWISE TREATMENT

Begin conservatively, escalate selectively

Treatment is guided by symptoms, objective evidence of reflux, anatomy and individual circumstances. The most appropriate—not simply the newest—method is what matters.

FIRST LINE

Nutrition and daily habits

Recommendations are selected individually and should avoid unnecessary restriction.

  • When overweight, weight reduction can improve symptoms.
  • Avoid late meals; elevate the head of the bed for night-time reflux.
  • Smaller portions and personal triggers rather than rigid exclusion lists.
  • Stop smoking and be cautious with very high-fat meals.
MEDICATION

Effective acid control

Proton pump inhibitors are the main medical treatment. Timing, adherence and the lowest effective dose are reviewed regularly.

  • Usually taken before a meal
  • H2 blockers, alginates or antacids in selected situations
  • If symptoms persist, first verify diagnosis and correct use
An inadequate response to PPIs should only be assumed after timing, dose, adherence, possible alternative diagnoses and—where required—objective reflux evidence have been reviewed.
WHEN SURGERY MAY HELP

Restore anatomy, control reflux

Surgery is considered particularly for objectively proven reflux, troublesome regurgitation, a large or symptomatic hernia and selected complications. Endoscopy, manometry and reflux testing form part of structured preoperative planning.

FOUNDATION

Hiatal reconstruction

The stomach is returned to the abdomen and the diaphragmatic crura are reconstructed behind the oesophagus. This is the central anatomical step for large hernias.

ESTABLISHED

Nissen fundoplication

A complete 360° wrap reinforces the reflux barrier. It is highly effective, but may have a greater effect on swallowing, belching and gas relief.

ESTABLISHED

Toupet fundoplication

A posterior partial wrap of approximately 270° may be an appropriate alternative, particularly with certain motility findings. Other partial wraps are used selectively.

INDIVIDUAL DECISION

There is no single best operation for everyone.

Choice is guided by hernia size, reflux evidence, oesophageal motility, swallowing function, previous surgery, body weight and personal priorities. Particular caution is required with unexplained dysphagia, relevant motility disorders, extraoesophageal symptoms without objective reflux evidence or high operative risk. With clinically relevant obesity, a bariatric strategy such as Roux-en-Y gastric bypass may be more appropriate.

CURRENT OPTIONS

Place newer procedures in context

Modern procedures broaden the range of options, but do not automatically replace established operations. Long-term evidence, revision options and centre experience form part of the decision.

Magnetic sphincter augmentation · LINX

For selected patients with objectively proven reflux, suitable anatomy and assessed motility. Device, erosion, removal and MRI considerations must be discussed.

TIF 2.0

Endoscopic reconstruction for selected patients with confirmed reflux, a small hernia and suitable anatomy. It is not suitable alone for larger hernias; long-term evidence is less extensive than for fundoplication.

cTIF

Combines surgical hernia repair with endoscopic TIF. The concept is plausible, but robust randomised long-term data remain limited.

RefluxStop

Available in selected European centres. Early and mid-term evidence is growing, but remains younger and less randomised than the evidence for established fundoplication procedures.

Roux-en-Y gastric bypass

An option for reflux with clinically relevant obesity or in complex revision situations. It is not a standard procedure for normal-weight reflux patients.

Other selective procedures

Stretta, endoscopic plication and other emerging approaches are considered only very selectively or within structured programmes because evidence and long-term comparative data are heterogeneous.

A new method should be judged by objective reflux evidence, suitable anatomy, multi-year outcomes, comparison with fundoplication or MSA, dysphagia and reoperation risk, and available revision options.
LARGE AND COMPLEX HERNIAS

Specialist planning for complex anatomy

With large paraoesophageal hernias, mechanical symptoms and the risk of entrapment or rotation often predominate. Surgery involves complete return of the stomach, management of the hernia sac, adequate oesophageal length and stable hiatal reconstruction.

Shortened oesophagus

In selected complex situations, a Collis lengthening procedure may be required so that the gastro-oesophageal junction rests in the abdomen without tension.

Risk of recurrence

Anatomical recurrence can occur even after careful reconstruction. Not every radiological recurrence causes symptoms or requires another operation.

Revision surgery

Repeat surgery after previous reflux or hernia procedures requires particularly precise diagnostics and should be planned in an experienced specialist centre.

BENEFITS, RISKS AND RECOVERY

Realistic goals, safe recovery

The goal is to improve heartburn and regurgitation, restore anatomy, protect the mucosa and improve quality of life. Complete freedom from symptoms or medication cannot be guaranteed.

Possible risks

  • Bleeding, infection, thrombosis and anaesthetic risks
  • Injury to adjacent structures or opening of the pleura
  • Temporary or persistent swallowing difficulty
  • Gas-bloat and reduced ability to belch or vomit
  • Recurrent reflux, hernia recurrence or reoperation
  • Procedure- or device-specific risks

Seek urgent help after surgery

  • Increasing breathlessness, chest or upper abdominal pain
  • Fever or a marked decline in general condition
  • Inability to swallow liquids or persistent vomiting
  • Vomiting blood, black stools or circulatory symptoms
  • Wound redness, swelling or discharge
  • Persistent or worsening swallowing difficulty
During the first weeks, diet is usually progressed gradually from liquids to soft food. Small bites, thorough chewing, slow eating and individually adjusted increases in activity support healing.
DECISION PATHWAY

A stepwise route to the right treatment

The decision is built from symptoms, objective findings and your personal goals—not from a single test or a preferred technique.

Understand symptoms

Pattern, triggers, warning signs and previous treatment.

Assess anatomy

Endoscopy and, when needed, contrast imaging or CT.

Measure function

Manometry and objective reflux monitoring.

Compare options

Discuss benefits, limitations, risks and alternatives transparently.

Decide individually

Continue conservative care or proceed with selected surgery.

FREQUENTLY ASKED QUESTIONS

Clear answers at a glance

These answers provide orientation. Individual recommendations always depend on examination and findings.

Can medication remove a hiatal hernia?

No. Medication can reduce acid effects and thereby symptoms or mucosal injury, but it does not change the anatomical hernia.

Will I need PPIs for life?

Not always. Indication, dose and duration are reviewed regularly, with the lowest effective dose as the aim. Long-term treatment may be appropriate for certain complications.

Is robotic surgery inherently better for reflux?

No. Robotics is an operating platform, not a superior anti-reflux principle. Correct indication, quality of anatomical reconstruction and team experience are what matter.

Can I still belch or vomit after fundoplication?

This varies and depends partly on the type and tightness of the wrap. A complete wrap may affect these functions more than a partial wrap.

Do Barrett's surveillance checks stop after surgery?

No. Successful reflux surgery does not replace recommended endoscopic surveillance for Barrett's oesophagus.

Can a hernia recur?

Yes. Anatomical recurrence is possible, particularly with large or complex hernias. Whether further treatment is needed depends on symptoms and findings.

SCIENTIFIC BASIS

Guideline-informed patient information

This information is informed by established international guidelines and consensus recommendations. Procedures with younger, limited or heterogeneous long-term evidence are deliberately presented as selective options.

ACG Clinical Guideline · Diagnosis and Management of Gastroesophageal Reflux Disease · 2022
Lyon Consensus 2.0 · Modern diagnosis of GERD · Gut · 2024
SAGES Guidelines · Surgical Treatment of GERD · Multi-Society Consensus · 2021–2022
SAGES Guidelines · Surgical Treatment of Hiatal Hernias · 2024
ASGE Guideline · Endoscopic diagnosis and management of GERD · 2025
Device and outcome literature · LINX, TIF/cTIF, RefluxStop and selected emerging procedures

Medical information: This content is intended for general orientation and does not replace a personal medical examination, diagnosis or individual treatment recommendation. The appropriate treatment can only be determined after structured diagnostics and shared decision-making.

HERNIA & ABDOMINAL WALL SURGERY

Hernia & Abdominal Wall Surgery

Guideline-informed diagnosis and individually planned treatment of groin, ventral, incisional and parastomal hernias—with a particular focus on minimally invasive and robot-assisted reconstruction.

DEFINITION

What is a hernia?

A hernia develops when peritoneum, fatty tissue or an organ protrudes through a congenital or acquired weak point in the abdominal wall. The visible or palpable bulge consists of a fascial defect and a hernia sac. Symptoms range from pressure or discomfort to pain, although some hernias initially cause few symptoms.

A hernia generally does not heal by itself. Whether and when surgery is appropriate depends on type, symptoms, size, progression, risk of incarceration, other medical conditions and personal goals.
Medical cross-sectional illustration of a ventral abdominal wall hernia
Ventral hernia: tissue protrudes through a defect in the load-bearing fascial layer.
Anatomical weak points

Congenital or acquired weak areas, particularly in the groin canal, umbilicus or abdominal midline.

Previous operations

A surgical scar may permanently weaken the fascia and become the site of an incisional hernia.

Pressure & healing

Chronic cough, constipation, obesity, smoking, diabetes and impaired wound healing can contribute to development or progression.

TYPES OF HERNIA

Location shapes the strategy.

Hernias are not all treated in the same way. Location, size, previous operations and abdominal wall quality determine the approach, reconstruction and mesh plane.

Medical illustration of an inguinal hernia

Inguinal hernia

The hernia sac protrudes in the region of the inguinal canal. Direct and indirect groin hernias are distinguished; in women, femoral hernia requires particular consideration.

Medical illustration of a primary ventral hernia

Umbilical & ventral hernia

Primary ventral hernias arise without previous surgery, commonly at the umbilicus or above it in the midline.

Medical illustration of an incisional hernia through a healed abdominal scar

Incisional hernia

This develops at the site of previous abdominal surgery. For planning more complex cases, the EHS recommends cross-sectional imaging, usually CT or alternatively MRI.

Medical illustration of a parastomal hernia adjacent to an intestinal stoma

Parastomal hernia

The defect develops beside an intestinal stoma. Treatment and possible reconstruction must consider stoma function, symptoms and recurrence risk together.

When is urgent assessment needed?

Sudden severe or increasing pain, a firm irreducible bulge, nausea or vomiting, abdominal distension, inability to pass stool or wind, fever or reddened skin over the hernia may indicate incarceration or bowel involvement and require urgent assessment.

DIAGNOSIS

From examination to a reliable plan.

Many hernias can be identified clinically while standing and straining. Imaging supplements examination when the diagnosis is uncertain or the abdominal wall is complex.

History

Symptoms, progression, reducibility, previous operations and occupational demands.

Examination

Location, size, skin, stoma and abdominal wall function while lying and standing.

Imaging

Ultrasound for selected questions; CT or MRI for uncertain, large, recurrent or complex incisional hernias.

Risk profile

Weight, smoking, diabetes, medication, lung function and individual operative risks.

TREATMENT OPTIONS

The least access necessary. The reconstruction required.

The goal is not simply to close an opening, but to achieve durable functional reconstruction. The procedure is tailored to the hernia and the patient, rather than chosen from technique preference alone.

Medical illustration of open Lichtenstein inguinal hernia mesh repair
OPEN

Lichtenstein

An established open mesh repair of the groin. It may be appropriate for individual anaesthetic planning, certain previous operations or when a laparo-endoscopic approach is unsuitable.

Two-panel medical illustration of TAPP inguinal hernia repair with preperitoneal mesh
MINIMALLY INVASIVE

TAPP

In transabdominal preperitoneal repair, the abdominal cavity is inspected laparoscopically, the peritoneum is opened and a broad mesh is placed in the preperitoneal plane before the peritoneum is closed again.

Two-panel medical illustration of TEP inguinal hernia repair in the extraperitoneal plane
EXTRAPERITONEAL

TEP

In total extraperitoneal repair, dissection takes place entirely outside the peritoneal cavity. The mesh covers the full myopectineal orifice within the preperitoneal plane.

TAPP or TEP?

Both are established laparo-endoscopic mesh techniques. They differ mainly in access rather than in their fundamental objective. The HerniaSurge guideline emphasises tailored procedure choice and surgeon expertise. Minimally invasive repair can be advantageous particularly for bilateral hernias, selected recurrences after an anterior repair and suitable primary hernias. Previous operations, hernia size, sex, general health and anaesthetic risk are considered.

ABDOMINAL WALL RECONSTRUCTION

Close the fascia. Place mesh in a protected plane.

For midline incisional hernias, the EHS recommends mesh-based reconstruction, preferably with retromuscular mesh placement. The fascial defect should be closed where possible and mesh bridging avoided.

Cross-sectional medical illustration of retromuscular sublay mesh placement

Sublay / retromuscular

The mesh lies behind the rectus muscles and outside the free peritoneal cavity. This protected plane allows broad reinforcement of the reconstructed fascia.

Medical illustration of minimally invasive ventral hernia defect closure and mesh reinforcement

Minimally invasive reconstruction

Techniques such as eTEP or MILOS can reconstruct suitable abdominal walls through smaller access routes and allow extraperitoneal mesh placement.

Medical cross-sectional illustration of an incisional hernia

Complex incisional hernia

Large defects, recurrences, multiple previous operations or loss of domain require detailed CT planning and, when necessary, advanced reconstructive techniques.

Medical illustration of robot-assisted abdominal wall reconstruction with retromuscular mesh
ROBOT-ASSISTED SURGERY

Precise reconstruction through small access points

Robotics is a surgical platform. It can facilitate controlled dissection within the abdominal wall, intracorporeal fascial closure and broad retromuscular mesh placement. Instrument articulation and stable three-dimensional vision may be helpful in more complex minimally invasive reconstructions.

  • small access points in suitable hernias
  • precise suturing and reconstructive steps
  • potential for extraperitoneal mesh placement
  • not automatic: benefit depends on anatomy and expertise
Putting evidence in context: the 2023 EHS guideline considers open, laparoscopic and robotic approaches potentially appropriate when matched to patient and hernia characteristics and supported by relevant expertise. Comparative long-term evidence is currently insufficient to claim general superiority of robotics.
AFTER SURGERY

Mobilise safely, increase activity gradually.

The pathway depends on access, hernia size and the extent of reconstruction. Personal discharge and activity advice takes precedence over general timelines.

The first days

  • early mobilisation and regular short walks
  • pain medication according to the agreed plan
  • maintain hydration and avoid constipation
  • keep wounds clean and follow dressing advice

Activity & work

  • increase normal activity according to comfort
  • drive only when reactions are safe and medication is not impairing
  • obtain individual advice for sport, heavy lifting and physical work
  • attend follow-up and use support garments if advised

What may commonly occur

  • wound discomfort, tightness or temporary swelling
  • bruising or fluid collection in the former hernia space
  • temporary tiredness and reduced stamina

When to seek advice

  • pain that increases rather than improves
  • fever, chills, marked redness or wound discharge
  • persistent vomiting, abdominal distension or inability to pass stool or wind
  • shortness of breath, chest pain or one-sided leg swelling
SCIENTIFIC BASIS

Informed by European Hernia Society guidelines

This page summarises key recommendations in patient-friendly language. Guidelines support decision-making but do not replace individual assessment of anatomy, symptoms, risks and treatment goals.

Medical information: This content is intended for general orientation and does not replace personal medical examination, diagnosis or individual treatment advice. Acute warning signs require urgent medical assessment.

PROCTOLOGY & PELVIC FLOOR SURGERY

Proctology & Pelvic Floor Surgery

Modern diagnostics and individual treatment of conditions affecting the anal canal and rectum—with particular attention to function, continence and quality of life.

PATIENT INFORMATION

Individual treatment. Preserving function.

Proctology deals with conditions of the anal canal, rectum and the surrounding skin and soft tissues. Common conditions include haemorrhoidal disease, anal fissures, anal abscesses and anal fistulas. A pilonidal sinus—often called a pilonidal fistula—is also treated surgically, but is anatomically distinct from an anal fistula.

Many proctological conditions can be treated very effectively. In addition to established conservative and surgical approaches, minimally invasive techniques that preserve sphincter and healthy tissue are available. The aim is not simply to use the newest method, but to select the appropriate treatment based on symptoms, anatomy and stage of disease.

RECOGNISING SYMPTOMS

Typical symptoms

Proctological conditions can present in very different ways. A focused examination helps identify the cause reliably.

  • Bright red blood during or after bowel movements
  • Pain, burning or pressure in the anal area
  • Itching, skin irritation or recurrent moisture
  • Palpable swelling or lumps
  • Mucous or purulent discharge
  • Foreign-body sensation or tissue prolapse from the anal canal
  • Difficulty with anal hygiene
  • Recurrent inflammation or abscesses
  • Changed bowel habits or difficulty with evacuation
These symptoms are not automatically caused by haemorrhoids. Rectal bleeding in particular should be medically assessed, as other bowel conditions can cause similar symptoms.
STEP BY STEP

Careful diagnostics

Assessment begins with a detailed discussion of symptoms, their duration, bowel habits, previous operations, medication and accompanying conditions, followed by a focused examination.

01

Inspection

Assessment of the outer anal region for swelling, inflammation, fistula openings, fissures, skin changes or prolapse.

02

Rectal examination

Careful digital examination of the anal canal and rectum when appropriate and tolerable.

03

Anoscopy / proctoscopy

Examination of the inner anal canal and lower rectum, particularly for assessing internal haemorrhoids.

04

Endosonography / MRI

For complex or recurrent fistulas to visualise the tract, branches and relationship to the sphincter.

05

Colonoscopy

May be required depending on age, bleeding pattern, family history, screening status and additional symptoms.

CONDITIONS & TREATMENT

Treatment tailored to the findings

Conservative, surgical and modern minimally invasive procedures are carefully balanced according to individual anatomy and stage of disease.

01 · CONDITION

Haemorrhoidal disease

What are haemorrhoids?

Haemorrhoids are normal, highly vascular cushions in the anal canal that support fine continence together with the sphincter. Haemorrhoidal disease occurs only when they enlarge or descend and cause symptoms.

Typical symptoms include bright red bleeding, itching, moisture, mucous discharge, pressure or a foreign-body sensation and tissue protruding during bowel movements.

  • Constipation and straining
  • Prolonged time on the toilet
  • Frequent stools or chronic diarrhoea
  • Pregnancy and increased pelvic pressure
Goligher classification
GradeDescription
Grad IEnlarged haemorrhoids without external prolapse.
Grad IIProlapse during straining or bowel movements, with spontaneous reduction.
Grad IIIProlapse that must be manually reduced.
Grad IVPermanently prolapsed tissue that cannot be reduced, or does not remain reduced.
Conservative and outpatient treatment

In early disease, the priority is soft, formed stool without straining: a fibre-rich diet, adequate fluid intake, physical activity and treatment of constipation or chronic diarrhoea. Ointments or suppositories may provide short-term relief but do not correct the anatomical cause of advanced disease.

Rubber-band ligation places a small band over internal haemorrhoidal tissue so that it regresses. It is established particularly for symptomatic grade I and II disease and selected grade III cases. Sclerotherapy or infrared coagulation may also be considered depending on the findings.

Surgical procedures and laser treatment

Marked prolapse, larger external components or advanced disease may require haemorrhoidectomy. Targeted removal of enlarged nodules is highly effective and an established standard for advanced findings. Haemorrhoidal artery ligation closes supplying vessels and may be combined with mucopexy for mucosal prolapse; potentially less postoperative pain must be weighed against a higher recurrence risk depending on the initial findings.

Laser haemorrhoidoplasty (LHP) introduces a fine laser fibre into the enlarged cushion. Controlled energy coagulates and reduces the tissue. In selected grade II and III disease, studies show advantages in early pain, blood loss and recovery. Long-term evidence and recurrence outcomes are less consistent; LHP is a selective option, not inherently superior.

Prevention

Complete prevention is not always possible. Good long-term stool regulation, a fibre-rich diet, adequate fluid intake, regular activity, short toilet visits and avoiding straining can reduce symptoms and renewed stress.

02 · CONDITION

Perianal / anal abscess

Acute purulent inflammation

An anal abscess is an acute purulent inflammation around the anal canal and surrounding soft tissues. An abscess and a cryptoglandular anal fistula may represent different phases of the same process: the abscess is the acute phase, while a fistula tract may persist afterwards.

The most common cause is infection of small glands in the anal canal. Recurrent or atypical abscesses should be investigated for a fistula or another underlying condition.

  • Subanodermal
  • Intersphincteric
  • Ischioanal / ischiorectal
  • Supralevator or horseshoe abscess
Treatment and follow-up

A fully developed anal abscess generally cannot be cured with ointments or antibiotics alone. The key treatment is prompt surgical opening and adequate drainage. Antibiotics may be added for certain risks or systemic signs of infection, but do not replace drainage.

If a fistula is identified at the same time, further treatment depends on its course and sphincter involvement. Preserving sphincter function and continence is especially important. No reliable primary prevention is known; recurrent abscesses should prompt a targeted search for a fistula or underlying disease.

03 · CONDITION

Anal fistula

A tract between the anal canal and skin

An anal fistula is an abnormal tract connecting the anal canal or rectum with the skin around the anus. Many cryptoglandular fistulas develop after infection of anal glands or an anal abscess. Typical symptoms are recurrent pain, moisture, purulent discharge, itching or repeated abscesses.

  • Intersphincteric fistula
  • Transsphincteric fistula
  • Suprasphincteric fistula
  • Extrasphincteric fistula
Causes, classification and basic treatment

In addition to cryptoglandular fistulas, causes may include Crohn’s disease, previous surgery, injury or other conditions. Crohn-associated fistulas are often managed through interdisciplinary care. For surgical planning, the relationship to the sphincter is decisive: the more sphincter tissue involved, the more important a sphincter-preserving approach becomes.

A persistent cryptoglandular fistula usually does not heal reliably with medication alone. Acute infection may first require drainage or a seton. Superficial, low fistulas can be treated very effectively by fistulotomy provided there is no unacceptable continence risk. Higher or complex fistulas may be treated with advancement flap, LIFT, selected seton strategies, TROPIS, or endoscopic and laser-based procedures.

VAAFT · Video-Assisted Anal Fistula Treatment

VAAFT is a video-assisted, sphincter-preserving procedure. A thin fistuloscope is introduced through the external opening, allowing direct visualisation, irrigation and removal or coagulation of inflammatory tissue. Side branches can be identified and the internal opening treated or closed according to the findings.

Its advantage is direct endoscopic visualisation while largely preserving the sphincter. Evidence remains heterogeneous. VAAFT is a selective option, not a universal standard for every anal fistula.

FiLaC · Fistula-tract Laser Closure

FiLaC introduces a radially emitting laser fibre into the fistula tract. During controlled withdrawal, the tract wall is coagulated and contracted from within without dividing the sphincter. Healing rates vary and high-quality long-term data remain limited. FiLaC is therefore selected only after careful assessment of fistula anatomy.

Prevention and follow-up

No reliable primary prevention is known for cryptoglandular fistulas. Important measures include early treatment of an anal abscess, investigation of recurrent abscesses, treatment of underlying disease and consistent follow-up after surgery.

04 · CONDITION

Anal fissure

A tear in the delicate anal canal lining

Typical symptoms are severe cutting or burning pain during bowel movements that may persist for minutes to hours. A small amount of bright red blood is common. Hard stool, constipation, straining or repeated diarrhoea may contribute.

In chronic fissures, increased internal sphincter tension may impair local blood flow and healing. Atypical or multiple fissures should prompt assessment for underlying disease.

Conservative treatment

The priority is consistently soft stool through fibre, fluids, avoidance of straining and medication for stool regulation when needed. Warm sitz baths may relieve symptoms. In chronic fissures, topical nitrates or calcium-channel blockers such as diltiazem or nifedipine may reduce internal sphincter tension.

Botulinum toxin and surgery

Botulinum toxin injection can temporarily reduce muscle tension and support blood flow and healing, particularly after insufficient response to topical therapy. Lateral internal sphincterotomy is highly effective for chronic treatment-resistant fissures. Because sphincter surgery may affect continence, careful patient selection and alternative procedures where appropriate are essential.

Prevention

Normal, soft stool without straining is key. Adequate fibre and fluids, together with early treatment of constipation or persistent diarrhoea, can help prevent renewed mechanical injury.

05 · CONDITION

Pilonidal sinus

Pilonidal sinus—not the same as an anal fistula

A pilonidal sinus is an inflammatory condition of the skin and subcutaneous tissue in the cleft above the coccyx. Mechanical forces may drive hairs into the skin and cause chronic inflammation, small openings and branching sinus tracts.

  • Asymptomatic disease
  • Acute abscess-forming disease
  • Chronic symptomatic disease
Selecting treatment

An asymptomatic finding does not require prophylactic surgery. An acute abscess requires surgical drainage, which should not be delayed by antibiotics. In chronic symptomatic disease, treatment depends on extent, number of openings, previous operations and individual factors.

Limited disease may be suitable for pit picking, sinusectomy, endoscopic treatment or laser ablation. More extensive or recurrent disease may be better managed in the long term with larger off-midline procedures.

EPSiT · Endoscopic Pilonidal Sinus Treatment

EPSiT introduces a thin endoscope through a small opening into the sinus system. Under direct vision, the tract and branches are assessed, hair and foreign material are removed, and inflammatory tissue is cleared or coagulated. The aim is small access points and limited tissue damage. Long-term evidence remains limited, and patient selection is crucial.

SiLaC · Laser ablation

SiLaC involves careful cleaning of the tract system followed by internal coagulation using a radially emitting laser fibre. Small skin openings and a limited wound area are potential advantages. Long-term comparative data remain limited, and laser treatment does not inherently replace larger operations in extensive or recurrent disease.

Prevention

No single preventive measure has proven universally effective. Good local hygiene, reduction of modifiable risk factors and early assessment of new symptoms are reasonable. Routine hair removal is not required for everyone and should be discussed individually.

TECHNOLOGY WITH JUDGEMENT

Modern minimally invasive proctology

Modern technologies broaden the treatment spectrum. They often aim to preserve the sphincter and healthy tissue while reducing postoperative burden.

ProcedureConditionPrincipleClinical context
Laser HemorrhoidoplastyHaemorrhoidsLaser coagulation and volume reductionMinimally invasive for selected findings; long-term outcomes and recurrence risk must be considered.
VAAFTAnal fistulaEndoscopic visualisation, cleaning and treatmentSphincter-preserving; long-term evidence remains limited.
FiLaCAnal fistulaRadial laser coagulation of the fistula tractSphincter-preserving; heterogeneous results make patient selection important.
EPSiTSinus pilonidalisEndoscopic cleaning under direct visionSmall access points; an option for selected findings.
SiLaCSinus pilonidalisLaser ablation of the cleaned sinus tractMinimally invasive; long-term comparative evidence remains limited.
IMPORTANT PRINCIPLE

Minimally invasive does not automatically mean superior.

The choice of procedure is guided by anatomy, stage of disease, sphincter involvement, recurrence risk, accompanying conditions and individual needs. The aim is not only to treat the disease, but to preserve function, continence and quality of life as effectively as possible. Benefits, limitations, risks and alternatives are discussed carefully before treatment.

SCIENTIFIC BASIS

Guideline-informed information

This patient information is informed by current German S3 guidelines and recommendations from international professional societies. Procedures with limited or heterogeneous long-term evidence are deliberately presented as selective options.

  • S3 Guideline: Cryptoglandular Anal Fistulas · Version 3.0/2026 · AWMF 088-003register.awmf.org
  • S3 Guideline: Anal Abscess · Version 3.0/2026 · AWMF 088-005register.awmf.org
  • S3 Guideline: Pilonidal Sinus · Version 3.0/2026 · AWMF 081-009register.awmf.org
  • ASCRS Clinical Practice Guidelines · Hemorrhoids (2024) & Anal Fissures (2023)fascrs.org
  • Current systematic reviews of laser haemorrhoidoplastyPubMed
ROBOTIC AND MINIMALLY INVASIVE SURGERY

Progress that
enables precision.

Robotic & Minimally Invasive Surgery

With the da Vinci surgical system, I use advanced technology to plan minimally invasive surgery precisely and individually. Its suitability is always assessed according to the condition and the patient’s personal situation.

My experience in robotic surgery combines extensive operative expertise with the development and advancement of modern robotic surgery programs. A particular focus is complex colorectal surgery, where precise dissection, controlled suturing and the least traumatic approach possible are essential.

DA VINCI XI SURGICAL SYSTEM

Robotic Surgery in Motion

The da Vinci Xi Surgical System supports the surgeon during complex minimally invasive procedures through high-definition 3D visualization and highly articulated surgical instruments.

The surgeon's movements are precisely translated to the instruments. The surgeon remains in complete control of every movement and every step of the procedure at all times.

The video provides an insight into the technology and demonstrates the interaction between the surgeon console, robotic system and modern minimally invasive surgery.

The da Vinci system does not operate autonomously. Every movement of the instruments is controlled by the surgeon.
3D HD visionMagnified three-dimensional visualisation of anatomical structures.
Fine instrumentsHigh mobility and controlled movement transfer.
Minimally invasive accessSmall surgical access points when medically appropriate.
Individual planningEvery procedure is tailored to your situation.

YOUR PATH WITH DA VINCI

The treatment journey

01
Initial consultationMedical history and discussion of your symptoms.
02
DiagnosticsPrecise assessment of your situation.
03
Surgical planningIndividual definition of the approach.
04
Robotic operationMinimally invasive procedure with precise control.
05
AftercareStructured postoperative support.
PATIENT INFORMATION

How Robotic-Assisted Surgery Works

Robotic-assisted surgery is an advanced form of minimally invasive surgery. The system does not operate independently: a trained surgeon controls the camera and every surgical instrument throughout the procedure.

The surgeon is always in controlIf the surgeon stops moving, the instruments stop. The system does not make decisions or perform surgical steps on its own.
Diagram showing that the surgeon controls the console, the robotic system translates the surgeon's movements in real time, and the instruments respond inside the body
The surgical system translates the surgeon’s hand movements into precise instrument movements in real time.
01
THE TECHNOLOGY

How the technology works

A robotic-assisted surgical system is a computer-controlled instrument platform consisting of a surgeon console, a patient-side unit with articulated arms, a high-definition camera and small surgical instruments. The surgeon and the operating-room team remain in the same room with the patient.

1
The surgeon controls the console

The surgeon views the surgical area in magnified three-dimensional detail and chooses every action: where to move, when to grasp tissue, when to cut and when to suture.

2
Movements are translated in real time

Hand movements are transferred immediately to the instruments. Motion scaling and tremor filtering can support precise work without replacing the surgeon’s knowledge, judgement or responsibility.

3
The instruments respond inside the body

A camera and fine articulated instruments are introduced through small access points. The surgeon uses the magnified view to identify anatomy and perform each operative step.

02
THE PROCEDURE

What happens during the operation?

1
Preparation & anaesthesia

General anaesthesia, safe positioning and standard safety checks are completed before the operation begins.

2
Small access points

The surgeon creates small incisions, inserts the ports and positions the robotic arms. Connecting the arms to the instruments is called docking.

3
Surgeon-controlled procedure

The surgeon performs the operation at the console. An assistant remains beside the patient, while the anaesthesia team continuously monitors the patient.

4
Completion & closure

The system is moved away and the small incisions are closed. A change to laparoscopy or open surgery may be made whenever the surgeon considers it safer.

POTENTIAL BENEFITS

Why robotic assistance may be helpful

Depending on the procedure and the individual patient, robotic assistance may offer enhanced visualisation, precise instrument control and improved access in confined spaces. Some patients may experience less postoperative pain, smaller scars or a faster recovery than after open surgery; these benefits vary and are not guaranteed.

Sources consulted in the patient information document: U.S. Food and Drug Administration, “Computer-Assisted Surgical Systems”; Kingston and Richmond NHS Foundation Trust, “Robot-assisted surgery”. This information does not replace personal medical advice.

CLINICAL OVERVIEW

Robotic & Minimally Invasive Visceral Surgery

Modern visceral surgery combines advanced technology with proven clinical outcomes. Robotic and minimally invasive techniques represent the current standard in many complex abdominal procedures, offering significant benefits over traditional open surgery.

Smaller Incisions, Faster Recovery

Minimally invasive surgery requires only small incisions (typically 5–15 mm for laparoscopy, similar or smaller for robotic assistance). This approach dramatically reduces tissue trauma, leading to shorter hospital stays, faster return to normal activities, and reduced postoperative pain. Studies consistently demonstrate that patients recover 2–3 times faster compared to open procedures.

Reduced Surgical Trauma & Complications

The minimally invasive approach decreases blood loss, reduces infection risk, and minimizes adhesion formation—a major cause of complications like bowel obstruction years after surgery. Prospective randomized trials, including the ROLARC study for colorectal cancer and the JALAPEÑO trial for gastric cancer, confirm that robotic and laparoscopic approaches achieve comparable oncologic outcomes to open surgery with fewer complications.

Enhanced Precision & Visualization

Robotic systems provide superior visualization with 3D, high-magnification imaging and instruments with greater dexterity and precision than the human hand. This is particularly valuable in complex dissections, anastomoses, and procedures requiring fine motor control. Laparoscopic instruments also offer magnified vision, enabling meticulous technique even in challenging anatomy.

Less Postoperative Pain & Fewer Scars

Smaller incisions mean minimal scar formation, reduced wound complications, and significantly lower pain levels postoperatively. Most patients require reduced analgesia requirements, improving quality of life immediately after surgery.

Equivalent Oncologic Outcomes

For cancer surgery (colorectal, gastric, and others), robotic and laparoscopic techniques achieve equivalent lymph node harvest, R0 resection rates, and long-term survival compared to open approaches. This has been validated in multiple randomized controlled trials and large prospective series, making these techniques the standard of care in high-volume centers.

Lower Impact on Pulmonary & Metabolic Function

The reduced inflammatory response and smaller incisions preserve core stability and respiratory function better than open surgery. Patients maintain better pulmonary function postoperatively and experience less systemic metabolic derangement, which is especially important in elderly or comorbid patients.

When Is Minimally Invasive Surgery Appropriate?

While most common visceral procedures (colorectal resections, gastrectomy, bariatric surgery, splenectomy, and others) can be performed safely with minimally invasive techniques, patient selection is crucial. Complex anatomy, emergency situations with hemodynamic instability, or extensive adhesions may warrant conversion to open surgery—and this is the mark of good surgical judgment, not failure.

Our Approach

We employ robotic and laparoscopic techniques as the standard approach for appropriate cases, with extensive training and proven outcomes. Every procedure is individualized based on patient factors, pathology, and operative findings. Our commitment is to provide the safest, most effective care with the smallest possible impact on your recovery.

For specific questions about your procedure and whether minimally invasive surgery is right for you, we encourage you to discuss this in detail during your consultation.

Evidence Base: This information is based on established guidelines from major surgical societies (SAGES, EAES), prospective randomized trials (ROLARC, JALAPEÑO), and current literature in visceral surgery. Individual outcomes vary based on patient factors and pathology.

Research & Publications

Academic work in robotic, colorectal, metabolic and minimally invasive surgery.

RESEARCH

Robotic Surgery

Advancement of robotic surgical procedures and clinical treatment concepts.

CLINICAL SCIENCE

Colorectal & Metabolic

Research projects in colorectal, bariatric and metabolic surgery.

INNOVATION

Digital Surgery & AI

Perspectives for data analysis, quality improvement and intraoperative support.

Research & Publications

Academic work in robotic, colorectal, metabolic and minimally invasive surgery.

RESEARCH

Robotic Surgery

Advancement of robotic surgical procedures and clinical treatment concepts.

CLINICAL SCIENCE

Colorectal & Metabolic

Research projects in colorectal, bariatric and metabolic surgery.

INNOVATION

Digital Surgery & AI

Perspectives for data analysis, quality improvement and intraoperative support.

SCIENTIFIC WORK

15 Recent Publications

Selected from the latest PubMed records for Omar Thaher. Open any publication to read the complete entry on PubMed.

012026Surgery Open ScienceLetter

Timing of a laparoscopic cholecystectomy in acute moderately severe to severe biliary pancreatitis

Pouwels S, Thaher O, Bausch D, et al.
PUBMED
022026European Journal of Surgical Oncology

Thromboprophylaxis, pain and organization: How do expert centers manage PIPAC's perioperative care? An international survey

Fawaz J, Hübner M, Ezanno AC, et al. · Collaborative Authorship Group
PUBMED
032026Cell Reports MedicineConsensus Statement

An international multidisciplinary consensus statement on laparoscopic liver biopsy

Lei SY, Han Y, Rockey DC, et al. · Including Thaher O
PUBMED
042026Journal of Laparoendoscopic & Advanced Surgical TechniquesSystematic Review

Esophageal Reflux Barrier Might be More than Just An Anatomical Definition: A Systematic Literature Review

Elshafei M, Pouwels S, Aiolfi A, et al. · Including Thaher O
PUBMED
052026Surgical Laparoscopy, Endoscopy & Percutaneous Techniques

Gender-specific Differences in Preoperative Characteristics and Perioperative Outcomes of Patients Undergoing Robotic Resection Rectopexy With NOSE for Obstructive Defecation Syndrome

Driouch J, Sajid S, Thaher O
PUBMED
062026BMC Surgery

Minimally invasive resection rectopexy as a treatment method for obstructive defecation (ODS): functional outcome in ODS; constipation and fecal incontinence

Driouch J, Schlaffke L, Sajid S, Bausch D, Thaher O
PUBMED
072025Updates in SurgeryMulticenter Study

Thromboembolic prophylaxis in bariatric and metabolic surgery: state-of-the-art according to the results of a nationwide registry study

Thaher O, Wendt E, Hukauf M, Croner RS, Stroh C
PUBMED
082025The LancetGBD 2023

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023

GBD 2023 Disease and Injury and Risk Factor Collaborators
PUBMED
092025MedicinaSystematic Review

Outcomes of Endoscopic Sleeve Gastroplasty: A Systematic Review

Vargas VPS, Thaher O, Elshafei M, Pouwels S, Pape-Köhler C
PUBMED
102025Obesity SurgeryScoping Review

Lipedema after Bariatric and Metabolic Surgery: A Scoping Review

Zevallos A, Schmidt J, Thaher O, Bausch D, Pouwels S
PUBMED
112025Current Urology ReportsReview

Vascular and Anatomical Challenges in Renal Transplant Surgery; What a Urologist Needs to know

Oceguera IN, Thaher O, Bausch D, Pouwels S
PUBMED
122025Annals of Medicine & SurgeryReview

Predictive modeling for metastasis in oncology: current methods and future directions

Abbas GH, Khouri ER, Thaher O, Taha S, et al.
PUBMED
132025Minerva Surgery

Short- and mid-term functional outcomes of STARR procedure in obstructed defecation syndrome

Driouch J, Bausch D, Thaher O
PUBMED
142025Journal of Robotic Surgery

Robot-assisted mesh rectosacropexy and sigmoid colon resection for obstructive defecation syndrome: a two-stage surgical approach

Driouch J, Sajid S, Bausch D, Thaher O
PUBMED
152024EClinicalMedicineErratum

Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

Zhou XD, Chen QF, Yang W, et al. · Including Thaher O
PUBMED

Publication data verified via PubMed. Records are ordered by PubMed publication date, newest first.

Patient Information

Clear guidance before, during and after planned treatment.

PREPARATION

Before Surgery

Important information about preparation, medication and admission.

TREATMENT

Your Hospital Stay

Processes, ward rounds and the essential steps surrounding your operation.

AFTERCARE

After Discharge

Information on activity, nutrition, wound checks and follow-up appointments.

PATIENT INFORMATION

Patient Information for Surgery

Clear, evidence-informed guidance before, during and after planned surgery—with a particular focus on preparation, risk reduction and safe recovery.

PREPARATIONHOSPITAL STAYAFTERCARE
KEY POINTS AT A GLANCE

How you can support your recovery

Many factors that influence the course of surgery and recovery can be improved before the procedure. These include stopping smoking, reducing alcohol, regular activity, adequate hydration, balanced nutrition and structured preparation with a medication review and checklists.

Modifiable risk factors should be identified as early as possible and, where feasible, reduced before planned surgery.
An overview of the most important preoperative measures.
01
BEFORE SURGERY

Preparing well for your procedure

Good organisation, healthy habits and a complete medical overview help reduce avoidable risks.

ORGANISATION

Preparing for surgery

Good organisational and medical preparation helps prevent errors and makes the day of surgery run more smoothly. This includes the preoperative assessment, required laboratory tests, a review of your medication list and all documents needed for admission.

  • Bring an up-to-date medication and allergy list
  • Bring relevant reports, letters and identification
  • Follow the fasting instructions from your care team exactly
  • Arrange transport and an escort home if advised
RISK REDUCTION

Stopping smoking before surgery

Smoking increases the risk of pulmonary and cardiovascular complications, wound-healing problems and infection. Even a few weeks without nicotine can improve tissue oxygenation and healing.

Recommendation: stop as early as possible—ideally at least four weeks before surgery.
HEALTH HABITS

Reducing alcohol intake

Regular or high alcohol intake can increase perioperative risk. It may affect the immune system, liver function, blood clotting and the response to anaesthetic medicines.

Please be open about your actual intake. This allows the care team to assess risks safely and support you individually.
NUTRITION

Nutrition and malnutrition

Good nutritional status is particularly important before major surgery. Tell your care team if you have lost significant weight in recent months, have little appetite or can eat only very small amounts.

  • Aim for adequate protein and energy intake
  • Identify malnutrition early
  • Use dietetic support or oral supplements if recommended
BLOOD TESTS

Identifying anaemia and iron deficiency

Preoperative anaemia is not uncommon and should be identified as early as possible before major surgery. Common causes include iron deficiency, chronic inflammation, vitamin deficiency and other underlying conditions.

Timely testing can identify the cause and, where possible, allow treatment before surgery.
MEDICATION SAFETY

Medicines before surgery

Your care team needs a complete medication list. Blood thinners, diabetes medicines, insulin, steroids, heart medicines, painkillers, herbal preparations and supplements are particularly important.

Never stop medicines on your own. Which medicines should be paused, adjusted or continued depends on the procedure and your individual risk and will be decided by your surgical or anaesthesia team.
02
IN HOSPITAL

Safety and early recovery

Effective pain management, early mobilisation and structured care are central parts of your treatment pathway.

TREATMENT PATHWAY

During your hospital stay

In hospital, the focus is on safety, effective pain relief, early mobilisation and structured care. As soon as medically appropriate, drinking, eating and movement are gradually resumed.

  • Risk-adapted thrombosis prevention
  • Multimodal pain management
  • Early mobilisation
  • Early oral fluids and food when medically appropriate
03
AFTER DISCHARGE

Continuing your recovery safely at home

Wound care, adequate hydration, healthy nutrition, gradual activity and follow-up appointments support your ongoing recovery.

RECOVERY

Aftercare and wound care

Recovery does not end when you leave hospital. Follow your personal discharge plan and increase activity gradually. Attend arranged wound checks and follow-up appointments.

  • Care for the wound according to your individual instructions
  • Drink enough and eat a balanced diet
  • Increase activity gradually
  • Attend scheduled follow-up appointments

Your personal discharge plan

Your care team will provide instructions on wound care, showering, physical activity, nutrition and medicines. These individual instructions take priority.

Warning signs—seek prompt assessment

  • Increasing redness, swelling or pus-like discharge
  • Worsening pain or persistent bleeding
  • Fever, shortness of breath, marked weakness or circulatory problems
EVIDENCE AND SOURCES

Guideline-informed patient information

The content is informed by established guidelines and studies on ERAS®, perioperative risk reduction, nutrition, anaemia management and infection prevention.

ERAS® – Enhanced Recovery After Surgery

ERAS combines structured preoperative preparation, modern anaesthesia and surgical techniques, multimodal pain management, early mobilisation and early nutrition in a standardised pathway.

Smoking cessation

The WHO describes benefits particularly when smoking is stopped around four weeks or more before surgery.

Nutrition and anaemia

ESPEN and international consensus recommendations support early identification and treatment of malnutrition and preoperative anaemia.

Updated August 2026. This information is for general guidance and does not replace individual medical advice, surgical consent or anaesthetic assessment. For acute or severe symptoms, please contact your local emergency service or the nearest emergency department.

Your treatment begins with a personal consultation.

Personal surgical consultation · by individual appointment

GET IN TOUCH →
CONTACT & APPOINTMENT

Contact & Appointment Request

For a personal surgical consultation, please submit your request through the form. Your enquiry will then be reviewed individually.

Request an appointment

Please complete the details below. Required fields are marked with *.

SECURE REQUEST
Please do not include sensitive medical documents.0 / 700
Your details are used exclusively to process your enquiry.